{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:26:09Z","timestamp":1788312369356,"version":"build-2803163510"},"reference-count":80,"publisher":"Hogrefe Publishing Group","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vasa"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:p> Summary: Patients with peripheral arterial disease (PAD) are at very high risk of cardiovascular events, but risk factor management is usually suboptimal. This Joint Task Force from the European Atherosclerosis Society and the European Society of Vascular Medicine has updated evidence on the management on dyslipidaemia and thrombotic factors in patients with PAD. Guidelines recommend a low-density lipoprotein cholesterol (LDLC) goal of more than 50% reduction from baseline and &lt;1.4 mmol\/L (&lt;55 mg\/dL) in PAD patients. As demonstrated by randomized controlled trials, lowering LDL-C not only reduces cardiovascular events but also major adverse limb events (MALE), including amputations, of the order of 25%. Addition of ezetimibe or a PCSK9 inhibitor further decreases the risk of cardiovascular events, and PCSK9 inhibition has also been associated with reduction in the risk of MALE by up to 40%. Furthermore, statin- based treatment improved walking performance, including maximum walking distance, and pain-free walking distance and duration. This Task Force recommends strategies for managing statin-associated muscle symptoms to ensure that PAD patients benefit from lipid-lowering therapy. Antiplatelet therapy, either daily clopidogrel 75 mg or the combination of aspirin 100 mg and rivaroxaban (2\u00d72.5 mg) is also indicated to prevent cardiovascular events. Dual pathway inhibition (aspirin and rivaroxaban) may be considered following revascularization, taking into account bleeding risk. This Joint Task Force believes that adherence with these recommendations for lipid-lowering and antithrombotic therapy will improve the morbidity and mortality in patients with PAD. <\/jats:p>","DOI":"10.1024\/0301-1526\/a000969","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T10:01:23Z","timestamp":1636365683000},"page":"401-411","source":"Crossref","is-referenced-by-count":25,"title":["Lipid-lowering and anti-thrombotic therapy in patients with \t\t\t\t\tperipheral arterial disease"],"prefix":"10.1024","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8280-6689","authenticated-orcid":true,"given":"Jill J. F.","family":"Belch","sequence":"first","affiliation":[{"name":"The Institute of Cardiovascular Research, University \t\t\t\t\tof Dundee, Ninewells Hospital and Medical School, Ninewells Hospital, \t\t\t\t\t\tDundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Brodmann","sequence":"additional","affiliation":[{"name":"Division of Angiology, Medical University, \t\t\t\t\t\tGraz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Baumgartner","sequence":"additional","affiliation":[{"name":"Swiss Cardiovascular Centre, Division of Angiology, \t\t\t\t\tBern University Hospital, University of Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph J.","family":"Binder","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Medical University \t\t\t\t\tof Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Casula","sequence":"additional","affiliation":[{"name":"Epidemiology and Preventive Pharmacology Service \t\t\t\t\t(SEFAP), Department of Pharmacological and Biomolecular Sciences, University of \t\t\t\t\tMilan, Italy"},{"name":"IRCCS MultiMedica, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Heiss","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, \t\t\t\t\tUniversity of Surrey, Guildford, UK"},{"name":"Surrey and Sussex Healthcare NHS Trust, East Surrey \t\t\t\t\tHospital, Redhill, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kahan","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of \t\t\t\t\tClinical Sciences, Danderyd Hospital, Karolinska Institutet, \t\t\t\t\t\tStockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Parini","sequence":"additional","affiliation":[{"name":"Department of Medicine and Department of Laboratory \t\t\t\t\tMedicine, Karolinska Institutet, and Theme Inflammation and Ageing, Karolinska \t\t\t\t\tUniversity Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Poredos","sequence":"additional","affiliation":[{"name":"Department of Vascular Disease, University Medical \t\t\t\t\tCentre Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberico L.","family":"Catapano","sequence":"additional","affiliation":[{"name":"IRCCS MultiMedica, Milan, Italy"},{"name":"Department of Pharmacological and Biomolecular \t\t\t\t\tSciences, Universit\u00e0 degli Studi di Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale","family":"Tokg\u00f6zo\u011flu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hacettepe University \t\t\t\t\tFaculty of Medicine, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"101","reference":[{"key":"c1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(03)00204-1"},{"key":"c2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61249-0"},{"key":"c3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2018.01.019"},{"key":"c4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2016.12.023"},{"key":"c5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.11.077"},{"key":"c6","volume-title":"Cancer Facts & Figures 2019","author":"American Cancer Society","year":"2019"},{"key":"c7","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2019.02.001"},{"key":"c8","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.71.3.510"},{"key":"c9","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.8.884"},{"key":"c10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202063260605"},{"key":"c11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv006"},{"key":"c12","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526\/a000834"},{"key":"c13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx549"},{"key":"c14","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.01.021"},{"key":"c15","doi-asserted-by":"publisher","DOI":"10.1177\/1479164114560342"},{"key":"c16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005967"},{"key":"c17","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2007.03.034"},{"key":"c18","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000330"},{"key":"c19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx144"},{"key":"c20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz962"},{"key":"c21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.115.306249"},{"key":"c22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.06.046"},{"key":"c23","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e32833b7756"},{"key":"c24","doi-asserted-by":"publisher","DOI":"10.1177\/0003319708324925"},{"key":"c25","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0492-5"},{"key":"c26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.10.019"},{"key":"c27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.13415"},{"key":"c28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.303849"},{"key":"c29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.035432"},{"key":"c30","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455"},{"key":"c31","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx710"},{"key":"c32","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.18.2157"},{"key":"c33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2018.02.013"},{"key":"c34","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2017.03.001"},{"key":"c35","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2016.07.001"},{"key":"c36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000123.pub2"},{"key":"c37","first-page":"e686","volume":"135","author":"Gerhard-Herman MD","year":"2017","journal-title":"Circulation"},{"key":"c38","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx095"},{"key":"c39","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1709711"},{"key":"c40","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X19894055"},{"key":"c41","doi-asserted-by":"publisher","DOI":"10.1177\/000331970305400104"},{"key":"c42","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000090686.57897.F5"},{"key":"c43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.08.052"},{"key":"c44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.11.052"},{"key":"c45","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00833-6"},{"key":"c46","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pu.09.050188.001011"},{"key":"c47","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"c48","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00904-1"},{"key":"c49","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-016-0842-z"},{"key":"c50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2009.06.002"},{"key":"c51","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526.38.2.155"},{"key":"c52","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(03)00010-X"},{"key":"c53","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1410489"},{"key":"c54","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30290-0"},{"key":"c55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615664"},{"key":"c56","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801174"},{"key":"c57","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.032235"},{"key":"c58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.03.013"},{"key":"c59","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.046524"},{"key":"c60","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.312782"},{"key":"c61","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv043"},{"key":"c62","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.136101"},{"key":"c63","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-005-5686-z"},{"key":"c64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2019.03.012"},{"key":"c65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2012.03.003"},{"key":"c66","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht295"},{"key":"c67","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-7-201304020-00004"},{"key":"c68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.08.002"},{"key":"c69","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709118"},{"key":"c70","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.623"},{"key":"c71","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.000679"},{"key":"c72","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7329.71"},{"key":"c73","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09457-3"},{"key":"c74","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn534"},{"key":"c75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2010.04.027"},{"key":"c76","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2016.2811"},{"key":"c77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.524"},{"key":"c78","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32409-1"},{"key":"c79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.03.008"},{"key":"c80","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2000052"}],"container-title":["Vasa"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/econtent.hogrefe.com\/doi\/pdf\/10.1024\/0301-1526\/a000969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T08:22:30Z","timestamp":1677140550000},"score":1,"resource":{"primary":{"URL":"https:\/\/econtent.hogrefe.com\/doi\/10.1024\/0301-1526\/a000969"}},"subtitle":["European Atherosclerosis Society\/European Society of Vascular Medicine \t\t\t\t\tJoint Statement"],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10.1024\/0301-1526\/a000969"],"URL":"https:\/\/doi.org\/10.1024\/0301-1526\/a000969","relation":{},"ISSN":["0301-1526","1664-2872"],"issn-type":[{"value":"0301-1526","type":"print"},{"value":"1664-2872","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}